Target intelligence / Profile preview

Colonization surface antigen 6 (CS6) (CS6)

Target
CS6
Molecular classification
Bacterial adhesin, Surface protein complex, Chaperone-usher system protein
01

Overview

Colonization surface antigen 6 (CS6) is a major non-fimbrial adhesin expressed by Enterotoxigenic Escherichia coli (ETEC), a leading cause of bacterial diarrhea in children and travelers (Svennerholm, 2017). The CS6 complex is composed of four proteins—CssA, CssB, CssC, and CssD—where CssA and CssB serve as the structural subunits that facilitate binding to the host intestinal epithelium (Wolf et al., 1997; UniProt P0CK95). Unlike many other ETEC colonization factors that form long fimbriae, CS6 forms a thin, non-fimbrial coating on the bacterial surface (Tobias et al., 2010). Its primary biological function is to mediate the adherence of ETEC to the small intestine, which is a prerequisite for the delivery of enterotoxins that cause fluid secretion and diarrhea (Qadri et al., 2005). Because of its high prevalence in clinical ETEC strains, CS6 is a critical target for vaccine development, notably in the oral inactivated vaccine ETVAX (Lundgren et al., 2014). Therapeutic strategies focus on inducing mucosal IgA antibodies that sterically hinder CS6-mediated attachment, thereby preventing infection.

Other names
CS6Colonization factor antigen 6CFA/VICssABCD complexCssA/B/C/D complex
02

Mechanism of action

Induction of mucosal secretory IgA antibodies that bind to the CS6 complex, preventing bacterial attachment to the intestinal epithelium and subsequent toxin delivery.

03

Biological functions

Bacterial adhesionIntestinal colonizationHost-pathogen interaction
04

Disease associations

InfectionDiarrheaTraveler's diarrhea
05

Safety considerations

Gastrointestinal side effects from oral vaccinesStrain-specific immunityLower immunogenicity in infants in endemic regions
06

Interacting drugs

ETVAX

2 more in the full profile.

07

Biomarkers

Anti-CS6 secretory IgAAnti-CS6 IgGFecal anti-CS6 antibodies

Beyond the preview

Go deeper on Colonization surface antigen 6 (CS6) (CS6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization surface antigen 6 (CS6) (CS6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call